Erle T. Mast, Director at Somaxon Pharmaceuticals, Inc. (SOMX), sold 10,000 shares at $3.23 ($32K) on 2011-01-03, disclosed to the SEC on 2011-01-05.
Open-market sale of $32k SOMX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SNNA | BUY | 2017-08-01 | $101K | — | Filing → |
| CLVS | SELL | 2015-11-03 | $317K | — | Filing → |
| CLVS | SELL | 2015-10-02 | $271K | — | Filing → |